A defendant shall be punished by imprisonment for not more than ten months.

However, the execution of the above punishment shall be suspended for a period of two years from the date this judgment becomes final and conclusive.

Punishment of the crime

The Defendant is the representative of the food sales company called “D” in Yeongdeungpo-gu Seoul Metropolitan Government.

1. No one shall indicate or advertise that the name, manufacturing method, quality or nutrition labelling, genetic materials, associations of food, etc., and food history tracking and control labeling of foods, etc., which have efficacy or efficacy in preventing and treating diseases, or are likely to mislead or confuse as medicine or health functional foods, with regard to such labeling or advertising;

Nevertheless, from May 8, 2014 to November 20 of the same year, the Defendant advertised a product of “Madong Rabbb”, which is a general food, using the Internet (E) and leaflets, etc. from around the above “D office” from around May 8, 2014 to around November 20 of the same year, and the Defendant restrains the generation of cancer with strong antiviral viruss on the primary ingredients and growth materials, and is outstanding in treating chronic epidemia and brain damage.

There are efficacys that assist patients suffering from halogic materials in haloging their boness.

With respect to the raw materials of the City, the advertisement was made with the content that there is efficacy and effect in the prevention and treatment of diseases, such as the creation of the bones damaged by our body as well as the therapy, or that is likely to mislead or confuse them as medicine. In addition, with respect to the raw materials and components of the “Gwandong Raz T&C” as a general food and the “Madong Magdong Magdong RabDD”, the amount of the powder of the IGF-1 (person with the similarity of insulin insulgin) increased by 28% compared to the large group.

After the month, 24% increase and 30% increase after the month, and the amount of growth Homon was promoted by approximately 6 times as much.

YGF251 Growth Cirmons growth into IGF-1 (insulin similarity sulphs), and growth into a dyke cell and its growth into a dyke cell with a proliferation and dysium. Growth, development of key, development of fyke cells, proliferation of fyke cells, 160% of bridges, bridges;